Instrument Inactif

Communiqués Misonix, Inc.

Actions

MSON

US6048711039

Equipement, fournitures et distribution médicale

Communiqués

29/10/21	MISONIX INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
26/10/21	MISONIX INC : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
18/10/21	MISONIX INC : Other Events (form 8-K)	AQ
02/09/21	MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
02/09/21	MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)	PU
02/09/21	Misonix : Reports Fourth Quarter and Fiscal Year 2021 Financial Results	AQ
12/08/21	MISONIX INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
31/07/21	MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. - MSON	BU
29/07/21	Misonix : FORM OF VOTING AND SUPPORT AGREEMENT (Form 8-K)	PU
29/07/21	MISONIX INC : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
29/07/21	Misonix : Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix	AQ
29/07/21	Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results	GL
23/06/21	MISONIX INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
14/05/21	MISONIX INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
14/05/21	Misonix Appoints Patrick J. Beyer to Board of Directors	GL
10/05/21	Misonix to Participate in Upcoming May and June Virtual Investor Conferences	GL
06/05/21	Misonix: Fiscal Q3 Earnings Snapshot	AQ
06/05/21	MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
06/05/21	Misonix Reports Fiscal 2021 Third Quarter Financial Results	GL
20/04/21	Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6	GL
30/03/21	Misonix : Expands Ultrasonic Technology Capabilities to Address the Orthoplastics Market	AQ
04/03/21	Misonix Receives Health Canada Approval for neXus	GL
01/03/21	Misonix to Participate in Upcoming March Investor Conferences	GL
11/02/21	Misonix to Participate at Upcoming Investor Conferences	GL
04/02/21	Misonix: Fiscal 2Q Earnings Snapshot	AQ